1. Home
  2. HLLY vs KMDA Comparison

HLLY vs KMDA Comparison

Compare HLLY & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Holley Inc.

HLLY

Holley Inc.

N/A

Current Price

$3.19

Market Cap

506.3M

ML Signal

N/A

Logo Kamada Ltd.

KMDA

Kamada Ltd.

N/A

Current Price

$8.51

Market Cap

458.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HLLY
KMDA
Founded
1903
1990
Country
United States
Israel
Employees
1520
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
506.3M
458.6M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
HLLY
KMDA
Price
$3.19
$8.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
$4.57
$14.00
AVG Volume (30 Days)
838.9K
71.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
2.34%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.95
$14.04
Revenue Next Year
$5.75
$7.99
P/E Ratio
N/A
$24.59
Revenue Growth
N/A
N/A
52 Week Low
$1.60
$5.54
52 Week High
$4.48
$9.35

Technical Indicators

Market Signals
Indicator
HLLY
KMDA
Relative Strength Index (RSI) 28.49 46.87
Support Level $2.73 $6.69
Resistance Level $4.24 $8.88
Average True Range (ATR) 0.22 0.25
MACD -0.11 -0.07
Stochastic Oscillator 1.29 5.88

Price Performance

Historical Comparison
HLLY
KMDA

About HLLY Holley Inc.

Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: